Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100116398 | 10011639 | 8 | F | 2015 | 20150921 | 20140314 | 20150930 | EXP | PHHY2012CA040051 | NOVARTIS | 44.81 | YR | F | Y | 0.00000 | 20151001 | N | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100116398 | 10011639 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | D | 21008 | 30 | MG | /month | ||||||
| 100116398 | 10011639 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | D | 21008 | 20 | MG | /month | ||||||
| 100116398 | 10011639 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS/ONCE A MONTH) | D | 21008 | 30 | MG | /month | ||||||
| 100116398 | 10011639 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UG, ONCE/SINGLE (TEST DOSE) | D | 0 | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100116398 | 10011639 | 1 | Neuroendocrine tumour |
| 100116398 | 10011639 | 4 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100116398 | 10011639 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100116398 | 10011639 | Anxiety | |
| 100116398 | 10011639 | Blood pressure increased | |
| 100116398 | 10011639 | Hepatic neoplasm | |
| 100116398 | 10011639 | Ovarian disorder | |
| 100116398 | 10011639 | Palmar erythema | |
| 100116398 | 10011639 | Pancreatic carcinoma | |
| 100116398 | 10011639 | Post procedural complication | |
| 100116398 | 10011639 | Post procedural discharge | |
| 100116398 | 10011639 | Post procedural swelling | |
| 100116398 | 10011639 | Pyogenic granuloma | |
| 100116398 | 10011639 | Scar | |
| 100116398 | 10011639 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100116398 | 10011639 | 1 | 20120508 | 0 | ||
| 100116398 | 10011639 | 4 | 20120501 | 20120501 | 0 |